LAMOND DAVID purchased 13.5% of their position (250K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $325.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/17/2023ACC: 0001209191-23-046402
+250K
Net shares
Net buyer
$325.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
250K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+107.89K
Price / share
$1.32
Trade value
$142.41K
% of position
5.8%
8/15/2023
1.85M→1.95M
Common Stock
Indirect
Shares
+117.35K
Price / share
$1.29
Trade value
$151.38K
% of position
6.0%
8/16/2023
1.95M→2.07M
Common Stock
Indirect
Shares
+24.77K
Price / share
$1.29
Trade value
$31.95K
% of position
1.2%
8/17/2023
2.07M→2.10M
Total
Net shares
+250K
Net value
$325.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/15/2023 | P · Purchase | +107.89K | $1.32 | $142.41K | 5.8% | 1.85M | 1.95M |
| Common Stock Indirect | 8/16/2023 | P · Purchase | +117.35K | $1.29 | $151.38K | 6.0% | 1.95M | 2.07M |
| Common Stock Indirect | 8/17/2023 | P · Purchase | +24.77K | $1.29 | $31.95K | 1.2% | 2.07M | 2.10M |
| Total | +250K | $325.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.73M
Common Stock
DirectShares owned301.83K
Total
301.83K direct·1.73M indirect2.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.73M | Indirect |
| Common Stock | 301.83K | Direct |
| Total | 2.04M | 301.83K direct·1.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported